These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 16277125

  • 21. [Treatment of infections associated with Clostridium difficile].
    Szczesny A, Martirosian G.
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [Abstract] [Full Text] [Related]

  • 22. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP, Surawicz CM.
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [Abstract] [Full Text] [Related]

  • 23. Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
    Nair S, Yadav D, Corpuz M, Pitchumoni CS.
    Am J Gastroenterol; 1998 Oct; 93(10):1873-6. PubMed ID: 9772047
    [Abstract] [Full Text] [Related]

  • 24. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ, Wilcox MH.
    Clin Infect Dis; 2008 Jul 01; 47(1):63-5. PubMed ID: 18491959
    [No Abstract] [Full Text] [Related]

  • 25. Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Cherry RD, Portnoy D, Jabbari M, Daly DS, Kinnear DG, Goresky CA.
    Gastroenterology; 1982 May 01; 82(5 Pt 1):849-51. PubMed ID: 7060906
    [Abstract] [Full Text] [Related]

  • 26. Clostridium difficile-associated colitis.
    Hull MW, Beck PL.
    Can Fam Physician; 2004 Nov 01; 50():1536-40, 1543-5. PubMed ID: 15597970
    [Abstract] [Full Text] [Related]

  • 27. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG.
    Clin Infect Dis; 2008 May 15; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract] [Full Text] [Related]

  • 28. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW.
    Clin Infect Dis; 2000 Oct 15; 31(4):1012-7. PubMed ID: 11049785
    [Abstract] [Full Text] [Related]

  • 29. Treatment strategies for C. difficile associated diarrhea.
    Stepan C, Surawicz CM.
    Acta Gastroenterol Latinoam; 2007 Sep 15; 37(3):183-91. PubMed ID: 17955730
    [Abstract] [Full Text] [Related]

  • 30. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
    Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Hamill RJ.
    Clin Infect Dis; 2005 Jun 01; 40(11):1586-90. PubMed ID: 15889354
    [Abstract] [Full Text] [Related]

  • 31. Treatment of Clostridium difficile infection.
    Gerding DN, Muto CA, Owens RC.
    Clin Infect Dis; 2008 Jan 15; 46 Suppl 1():S32-42. PubMed ID: 18177219
    [Abstract] [Full Text] [Related]

  • 32. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S.
    J Infect; 2009 Jun 15; 58(6):403-10. PubMed ID: 19394704
    [Abstract] [Full Text] [Related]

  • 33. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM, O'Brien M, Kokkotou E, Eisenstein B, Michaelis A, Rothstein D, Paraschos S, Kelly CP, Pothoulakis C.
    Antimicrob Agents Chemother; 2004 Oct 15; 48(10):3975-9. PubMed ID: 15388461
    [Abstract] [Full Text] [Related]

  • 34. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB.
    Scand J Infect Dis; 2012 Apr 15; 44(4):243-9. PubMed ID: 22077148
    [Abstract] [Full Text] [Related]

  • 35. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
    Tedesco FJ, Gordon D, Fortson WC.
    Am J Gastroenterol; 1985 Nov 15; 80(11):867-8. PubMed ID: 4050760
    [Abstract] [Full Text] [Related]

  • 36. Intravenous immunoglobulin for resistant Clostridium difficile infection.
    Murphy C, Vernon M, Cullen M.
    Age Ageing; 2006 Jan 15; 35(1):85-6. PubMed ID: 16303776
    [Abstract] [Full Text] [Related]

  • 37. Diarrhea we can treat: antibiotic-associated colitis.
    Levine HG, Lamont JT.
    Compr Ther; 1982 Aug 15; 8(8):36-43. PubMed ID: 7128040
    [Abstract] [Full Text] [Related]

  • 38. Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    Hassoun A, Ibrahim F.
    Am J Geriatr Pharmacother; 2007 Mar 15; 5(1):48-51. PubMed ID: 17608247
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The approach to recurrent infections with Clostridium difficile].
    Paz Z, Altman A.
    Harefuah; 2008 Nov 15; 147(11):864-5, 942. PubMed ID: 19264004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.